ATRA vs KEY · rev $128.9M vs P/E 13, rev $7.51B
Atara Biotherapeutics Inc (ATRA) versus KeyCorp (KEY) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
KeyCorp (KEY) is a banks - regional company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported KEY revenue for 2025-12-31 was $7.51B. Net income was $1.83B. Revenue was up 62.7% from 2024-12-31 to 2025-12-31. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
ATRA currently screens at market cap $87.1M. KEY currently screens at market cap $22.64B and trailing P/E 12.8.
Not investment advice. Open the ATRA and KEY stock pages for the full models.
Not investment advice.